1. Home
  2. MEIP vs BLIN Comparison

MEIP vs BLIN Comparison

Compare MEIP & BLIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEIP
  • BLIN
  • Stock Information
  • Founded
  • MEIP 2000
  • BLIN 2000
  • Country
  • MEIP United States
  • BLIN United States
  • Employees
  • MEIP 28
  • BLIN N/A
  • Industry
  • MEIP Biotechnology: Pharmaceutical Preparations
  • BLIN EDP Services
  • Sector
  • MEIP Health Care
  • BLIN Technology
  • Exchange
  • MEIP Nasdaq
  • BLIN Nasdaq
  • Market Cap
  • MEIP 17.3M
  • BLIN 20.6M
  • IPO Year
  • MEIP 2003
  • BLIN 2007
  • Fundamental
  • Price
  • MEIP $2.60
  • BLIN $1.57
  • Analyst Decision
  • MEIP Hold
  • BLIN Strong Buy
  • Analyst Count
  • MEIP 2
  • BLIN 1
  • Target Price
  • MEIP $7.00
  • BLIN $4.62
  • AVG Volume (30 Days)
  • MEIP 7.5K
  • BLIN 137.4K
  • Earning Date
  • MEIP 02-12-2025
  • BLIN 02-13-2025
  • Dividend Yield
  • MEIP N/A
  • BLIN N/A
  • EPS Growth
  • MEIP N/A
  • BLIN N/A
  • EPS
  • MEIP N/A
  • BLIN N/A
  • Revenue
  • MEIP N/A
  • BLIN $15,394,000.00
  • Revenue This Year
  • MEIP N/A
  • BLIN $7.51
  • Revenue Next Year
  • MEIP N/A
  • BLIN $6.57
  • P/E Ratio
  • MEIP N/A
  • BLIN N/A
  • Revenue Growth
  • MEIP 33.76
  • BLIN N/A
  • 52 Week Low
  • MEIP $2.30
  • BLIN $0.76
  • 52 Week High
  • MEIP $4.42
  • BLIN $2.80
  • Technical
  • Relative Strength Index (RSI)
  • MEIP 37.79
  • BLIN 40.34
  • Support Level
  • MEIP $2.55
  • BLIN $1.65
  • Resistance Level
  • MEIP $2.79
  • BLIN $1.83
  • Average True Range (ATR)
  • MEIP 0.14
  • BLIN 0.19
  • MACD
  • MEIP -0.02
  • BLIN -0.05
  • Stochastic Oscillator
  • MEIP 14.71
  • BLIN 5.74

About MEIP MEI Pharma Inc.

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.

About BLIN Bridgeline Digital Inc.

Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: